REPAMADE V 0.5/0.3 TABLET

Product Description

REPAMADE V 0.5/0.3 TABLET
Composition: Repaglinide 0.5 mg + Voglibose 0.3 mg

Unlock effective blood sugar control with REPAMADE V 0.5/0.3 TABLET, a powerful combination therapy tailored for type 2 diabetes management. This formulation blends Repaglinide, a fast-acting insulin secretagogue, with Voglibose, an alpha-glucosidase inhibitor, to target postprandial hyperglycemia efficiently.

Key Benefits:

• Rapidly stimulates insulin release to manage glucose spikes after meals

• Delays carbohydrate absorption to maintain steady blood sugar levels

• Enhances overall glycemic control with minimal risk of hypoglycemia

• Suitable for adjunct therapy alongside diet and exercise

Usage:
Recommended for patients with type 2 diabetes mellitus requiring dual action therapy to control fasting and post-meal blood glucose levels. Ideal for medical distributors, pharmacies, and healthcare providers aiming to offer comprehensive diabetes care solutions.

Why Choose REPAMADE V 0.5/0.3 TABLET?

• High-quality pharmaceutical grade formulation

• Manufactured under stringent quality standards

• Competitive pricing for bulk buyers and distributors

• Trusted combination therapy for effective diabetes management